1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Drug News 05 OCTOBER 2015

Cancer Drug News 05 OCTOBER 2015

  • October 2015
  • -
  • Espicom Business Intelligence
  • -
  • 8 pages

Industry Trend Analysis - Roche's Entry Into Checkpoint Inhibition Market Imminent
Industry Brief - Phase II Xtandi Data Demonstrate Potential Advantages Of Genomic Profiling Assay
Industry Brief - R-Pharm US Acquires Ixempra From BMS
Industry Brief - Janssen's Daratumumab Accepted For CHMP Accelerated Assessment
Industry Trend Analysis - Wave Of Positive Anti-CSC Data Crucial To Rebuilding Confidence
Industry Brief - Data Support Continued Development Of Cyramza In Urothelial Carcinoma
Industry Brief - First Data From The Prostate Cancer Registry Released At ECC 2015
Industry Brief - Tasquinimod Does Not Improve OS In mCRPC
Industry Brief - Roche's anti-PDL1 Achieves Positive Results In Phase II mUC Study
Industry Brief - Blueprint Medicines Receives FDA ODD For HCC Candidate
Industry Brief - Merck/DNAtrix Enter Phase II Immuno-oncology Collaboration
Industry Brief - FDA Grants Avelumab ODD For Merkel Cell Carcinoma
Industry Brief - Opdivo+Yervoy Regimen Gains FDA Approval For BRAF V600 Wild-Type MM
Industry Trend Analysis - Novartis Deal Offers XOMA Recovery Opportunity
Industry Brief - Clovis Achieves US/EU Regulatory Milestones For Rociletinib
Industry Trend Analysis - Companion Diagnostic Not Enough To Secure Avelumab Market Share
Industry Brief - Yondelis Approved In Japan For STS

Table Of Contents

Cancer Drug News 05 OCTOBER 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident ...

Hematological Malignancies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Hematological Malignancies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • November 2016
  • by Transparency Market Research

Hematological Malignancies Market: Overview This report provides in-depth region wise and country wise analysis of the hematological malignancies market. Stakeholders of this report include manufacturers ...

Women’s Health Diagnostics Market by Application End User - Forecast to 2021

Women’s Health Diagnostics Market by Application End User - Forecast to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

Women's Health Diagnostics Market by Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.